V. Hricak

1.2k total citations · 1 hit paper
14 papers, 573 citations indexed

About

V. Hricak is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, V. Hricak has authored 14 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in V. Hricak's work include Infective Endocarditis Diagnosis and Management (7 papers), Streptococcal Infections and Treatments (4 papers) and Acute Myocardial Infarction Research (4 papers). V. Hricak is often cited by papers focused on Infective Endocarditis Diagnosis and Management (7 papers), Streptococcal Infections and Treatments (4 papers) and Acute Myocardial Infarction Research (4 papers). V. Hricak collaborates with scholars based in Slovakia, United States and United Kingdom. V. Hricak's co-authors include Frank Misselwitz, Pascual Bordes, Paul Burton, Rohan Poulter, C. Michael Gibson, В. А. Марков, Eugene Braunwald, Satishkumar Mohanavelu, Leonard Oppenheimer and Adam Witkowski and has published in prestigious journals such as The Lancet, International Journal of Antimicrobial Agents and Postgraduate Medical Journal.

In The Last Decade

V. Hricak

13 papers receiving 554 citations

Hit Papers

Rivaroxaban versus placebo in patients with acute coronar... 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Hricak Slovakia 6 495 265 89 67 44 14 573
Alfonso Noto Italy 5 143 0.3× 191 0.7× 38 0.4× 69 1.0× 37 0.8× 6 261
Diane Wirth United States 5 253 0.5× 233 0.9× 71 0.8× 48 0.7× 55 1.3× 12 397
Josef Schmitt Germany 7 446 0.9× 151 0.6× 40 0.4× 116 1.7× 11 0.3× 10 576
Lauren K. Stewart United States 9 143 0.3× 200 0.8× 42 0.5× 61 0.9× 22 0.5× 15 288
Siyang Peng United States 10 228 0.5× 88 0.3× 84 0.9× 48 0.7× 26 0.6× 21 414
Fossard Dp 7 118 0.2× 100 0.4× 171 1.9× 39 0.6× 15 0.3× 8 377
Jan Kilhamn Sweden 10 456 0.9× 110 0.4× 310 3.5× 19 0.3× 11 0.3× 19 619
Jean-François Deshaies Canada 5 80 0.2× 171 0.6× 41 0.5× 37 0.6× 20 0.5× 10 230
Panteleimon Ε. Papakonstantinou Greece 8 103 0.2× 26 0.1× 41 0.5× 99 1.5× 20 0.5× 32 258
Luis Mataix Spain 10 309 0.6× 72 0.3× 62 0.7× 209 3.1× 3 0.1× 15 403

Countries citing papers authored by V. Hricak

Since Specialization
Citations

This map shows the geographic impact of V. Hricak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Hricak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Hricak more than expected).

Fields of papers citing papers by V. Hricak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Hricak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Hricak. The network helps show where V. Hricak may publish in the future.

Co-authorship network of co-authors of V. Hricak

This figure shows the co-authorship network connecting the top 25 collaborators of V. Hricak. A scholar is included among the top collaborators of V. Hricak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Hricak. V. Hricak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Krčméry, V., V. Hricak, M Mrázová, et al.. (2019). Etiology, Risk Factors and Outcome of 1003 Cases of Infective Endocarditis from a 33-year National Survey in the Slovak Republic: An increasing proportion of elderly patients.. PubMed. 39(8). 544–549. 5 indexed citations
2.
Hricak, V., et al.. (2018). Transcatheter Mitral Valve Prosthesis Dysfunction ― Early Valve Degeneration or Thrombosis? ―. Circulation Journal. 82(8). 2210–2211.
3.
Wawruch, Martin, Gejza Wimmer, J. Luha, et al.. (2016). Patient-related characteristics associated with non-persistence with statin therapy in elderly patients following an ischemic stroke. Pharmacoepidemiology and Drug Safety. 26(2). 201–207. 17 indexed citations
4.
Studenčan, Martin, František Kovář, V. Hricak, et al.. (2014). Two-year survival of STEMI patients in Slovakia. An analysis of the SLOVak registry of Acute Coronary Syndromes (SLOVAKS). Cor et Vasa. 56(4). e297–e303. 1 indexed citations
6.
Hricak, V., et al.. (2013). P03 STAPHYLOCOCCUS AUREUS IN THE AETIOLOGY OF INFECTIVE ENDOCARDITIS IN SLOVAKIA DURING THE LAST SIX YEARS. International Journal of Antimicrobial Agents. 41. S7–S8. 2 indexed citations
7.
Piťha, Jan, et al.. (2012). Léčba statiny u pacientů s akutním koronárním syndromem. 11(2). 89–90. 3 indexed citations
8.
Studenčan, Martin, V. Hricak, František Kovář, et al.. (2011). Implementation of ESC-STEMI guidelines into clinical practice: an analysis of the Slovak Registry of Acute Coronary Syndromes (SLOVAKS). Journal of Cardiovascular Medicine. 12(5). 353–355. 3 indexed citations
9.
Braunwald, Eugene, Satishkumar Mohanavelu, Paul Burton, et al.. (2009). Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. The Lancet. 374(9683). 29–38. 488 indexed citations breakdown →
10.
Hricak, V., et al.. (2007). Trends in Risk Factors and Etiology of 606 Cases of Infective Endocarditis Over 23 Years (1984-2006) in Slovakia. Journal of Chemotherapy. 19(2). 198–202. 10 indexed citations
11.
Krčméry, V., et al.. (2003). Etiology and Risk Factors of 339 Cases of Infective Endocarditis: Report from a 10-year National Prospective Survey in the Slovak Republic. Journal of Chemotherapy. 15(6). 579–583. 28 indexed citations
12.
Hricak, V., et al.. (1999). Aetiology and outcome in 53 cases of native valve staphylococcal endocarditis. Postgraduate Medical Journal. 75(887). 540–543. 7 indexed citations
13.
Hricak, V., et al.. (1998). Native Valve Staphylococcal Endocarditis: Etiology, Risk Factors and Outcome in 53 Cases. Journal of Chemotherapy. 10(5). 360–368. 7 indexed citations
14.
Lichardus, B, et al.. (1995). [Personal experience with determination of endogenous, digoxin-like substances in patients with myocardial infarct and other cardiopathies].. PubMed. 96(2). 82–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026